appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Torrent Pharmaceuticals Ltd
TORNTPHARM
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit
2 weeks ago•Business Standard
Torrent Pharma’s Indrad facility gets Form 483 with 5 observations from US FDA
2 weeks ago•Business Standard
Buzzing stocks, June 13: BLS In’t, DrReddy’s, Sobha, Torrent Pharma, Gensol
2 weeks ago•Business Standard
Torrent Pharma Receives Form 483 With Five Observations From USFDA
2 weeks ago•Bloomberg Quint
Stocks To Watch: RVNL, BHEL, Torrent Pharmaceuticals, KPI Green Energy
3 weeks ago•Bloomberg Quint
Torrent Pharma Q4 Results Review - Another Quarter Of Strong Margins: Prabhdas Lilladher
1 month ago•Bloomberg Quint
Torrent Pharma Shares Hit Record On Post Result Target Price Hikes
1 month ago•Bloomberg Quint
Stocks To Watch: LIC, Torrent Pharma, NTPC, United Spirits
1 month ago•Bloomberg Quint
Torrent Pharma Plans To Raise Rs 5,000 Crore Through QIP
1 month ago•Bloomberg Quint
Q4 Results Today: Hindalco, NTPC, Torrent Pharma Among 250+ Companies To Report Earnings
1 month ago•Bloomberg Quint
Recent EventsAll events
Outcome of Board Meeting-XBRL
Cash Dividend
Final • Div/Share: ₹ 6
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant